EIDP, Inc.CTA-PB
EIDP, Inc. Segments Disclosure
SEGMENT INFORMATION
Corteva’s reportable segments reflect the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (Seed and Crop Protection). The company's CODM is the Chief Executive Officer. The primary measure used by Corteva's CODM for purposes of allocating resources to the segments and assessing segment performance is segment operating EBITDA.
Segment operating EBITDA is primarily utilized in the annual planning and monthly forecasting processes. On a monthly basis, the CODM considers variances between comparable prior year actual results and current year actual or forecasted results when evaluating the company's success in delivering its innovative proprietary technology to farmers and monitoring of expected savings from cost and productivity actions. The CODM also utilizes segment operating EBITDA when evaluating the impacts of market-driven trends on segment performance, such as input costs and inflationary and currency impacts.
The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items and separation costs. Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility.
Corporate Profile
The company conducts its global operations through the following reportable segments:
Seed
The company's Seed segment is a global leader in developing and supplying commercial seed combining advanced germplasm and traits that offer maximum yield potential for farmers around the world. The segment is a leader in many key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The company offers seed and trait technologies that boost resilience to weather, pests, diseases, and herbicides used to manage weeds. Its digital solutions provide data-driven insights to help farmers optimize yield and profitability.
Crop Protection
The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that support overall crop health both above and below ground via nitrogen management and seed-applied technologies. The segment offers crop protection solutions and digital solutions that provide farmers tools to improve productivity and profitability, and help keep fields free of weeds, insects and diseases. The segment is a leader in global herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products.
(In millions) | Seed | Crop Protection | Total | ||||||||
| As of and for the Year Ended December 31, 2025 | |||||||||||
| Net sales | $ | 9,898 | $ | 7,503 | $ | 17,401 | |||||
| Segment operating EBITDA | 2,636 | 1,350 | 3,986 | ||||||||
| Depreciation and amortization | 780 | 423 | 1,203 | ||||||||
| Purchases of property, plant and equipment | 377 | 214 | 591 | ||||||||
| As of and for the Year Ended December 31, 2024 | |||||||||||
| Net sales | $ | 9,545 | $ | 7,363 | $ | 16,908 | |||||
| Segment operating EBITDA | 2,219 | 1,272 | 3,491 | ||||||||
| Depreciation and amortization | 805 | 422 | 1,227 | ||||||||
| Purchases of property, plant and equipment | 365 | 232 | 597 | ||||||||
| As of and for the Year Ended December 31, 2023 | |||||||||||
| Net sales | $ | 9,472 | $ | 7,754 | $ | 17,226 | |||||
| Segment operating EBITDA | 2,117 | 1,374 | 3,491 | ||||||||
| Depreciation and amortization | 814 | 397 | 1,211 | ||||||||
| Purchases of property, plant and equipment | 332 | 263 | 595 | ||||||||
Reconciliation of Segment Profitability
| (In millions) | Seed | Crop Protection | Total | ||||||||
| For the Year Ended December 31, 2025 | |||||||||||
| Net sales | $ | 9,898 | $ | 7,503 | $ | 17,401 | |||||
| Cost of goods sold | 4,533 | 4,585 | 9,118 | ||||||||
Other expenses 1 | 2,729 | 1,568 | 4,297 | ||||||||
| Segment operating EBITDA | $ | 2,636 | $ | 1,350 | $ | 3,986 | |||||
| (In millions) | Seed | Crop Protection | Total | ||||||||
| For the Year Ended December 31, 2024 | |||||||||||
| Net sales | $ | 9,545 | $ | 7,363 | $ | 16,908 | |||||
| Cost of goods sold | 4,876 | 4,636 | 9,512 | ||||||||
Other expenses 1 | 2,450 | 1,455 | 3,905 | ||||||||
| Segment operating EBITDA | $ | 2,219 | $ | 1,272 | $ | 3,491 | |||||
| (In millions) | Seed | Crop Protection | Total | ||||||||
| For the Year Ended December 31, 2023 | |||||||||||
| Net sales | $ | 9,472 | $ | 7,754 | $ | 17,226 | |||||
| Cost of goods sold | 4,982 | 4,913 | 9,895 | ||||||||
Other expenses 1 | 2,373 | 1,467 | 3,840 | ||||||||
| Segment operating EBITDA | $ | 2,117 | $ | 1,374 | $ | 3,491 | |||||
1. Other expenses consist primarily of selling, general and administrative expenses and research and development expense, net of depreciation add-back.
Reconciliation to Consolidated Financial Statements
| Income (loss) from continuing operations after income taxes to segment operating EBITDA | For the Year Ended December 31, | ||||||||||
| (In millions) | 2025 | 2024 | 2023 | ||||||||
| Income (loss) from continuing operations after income taxes | $ | 1,204 | $ | 863 | $ | 941 | |||||
| Provision for (benefit from) income taxes on continuing operations | 484 | 412 | 152 | ||||||||
| Income (loss) from continuing operations before income taxes | $ | 1,688 | $ | 1,275 | $ | 1,093 | |||||
| Depreciation and amortization | 1,203 | 1,227 | 1,211 | ||||||||
| Interest income | (136) | (132) | (283) | ||||||||
| Interest expense | 180 | 233 | 233 | ||||||||
| Exchange (gains) losses - net | 181 | 284 | 397 | ||||||||
| Non-operating (benefits) costs - net | 39 | 174 | 151 | ||||||||
| Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | — | — | — | ||||||||
| Significant items | 658 | 315 | 579 | ||||||||
| Separation costs | 35 | — | — | ||||||||
| Corporate expenses | 138 | 115 | 110 | ||||||||
| Segment operating EBITDA | $ | 3,986 | $ | 3,491 | $ | 3,491 | |||||
Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA
The years ended December 31, 2025, 2024 and 2023, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:
| (In millions) | Seed | Crop Protection | Corporate | Total | ||||||||||
| For the Year Ended December 31, 2025 | ||||||||||||||
Restructuring and asset related charges - net 1 | $ | (4) | $ | (135) | $ | (7) | $ | (146) | ||||||
Bayer resolution 2 | (610) | — | — | (610) | ||||||||||
Gain (loss) on sale of business, assets and equity investments 3,4 | — | 37 | — | 37 | ||||||||||
AltEn facility remediation charges 5 | (37) | — | — | (37) | ||||||||||
Insurance proceeds 6 | — | 98 | — | 98 | ||||||||||
| Total | $ | (651) | $ | — | $ | (7) | $ | (658) | ||||||
| (In millions) | Seed | Crop Protection | Corporate | Total | ||||||||||
| For the Year Ended December 31, 2024 | ||||||||||||||
Restructuring and asset related charges - net 1 | $ | (55) | $ | (142) | $ | (91) | $ | (288) | ||||||
Gain (loss) on sale of business, assets and equity investments 4 | 4 | 3 | — | 7 | ||||||||||
Inventory write-offs 4 | 2 | — | — | 2 | ||||||||||
Insurance proceeds 6 | — | 71 | — | 71 | ||||||||||
Estimated settlement expense 7 | — | (101) | — | (101) | ||||||||||
Acquisition-related costs 8 | — | (6) | — | (6) | ||||||||||
| Total | $ | (49) | $ | (175) | $ | (91) | $ | (315) | ||||||
| (In millions) | Seed | Crop Protection | Corporate | Total | ||||||||||
| For the Year Ended December 31, 2023 | ||||||||||||||
Restructuring and asset related charges - net 1 | $ | (86) | $ | (228) | $ | (22) | $ | (336) | ||||||
Gain (loss) on sale of business, assets and equity investments 4 | 4 | 10 | — | 14 | ||||||||||
Inventory write-offs 4 | (7) | — | — | (7) | ||||||||||
Spare parts write-off 3 | — | (12) | — | (12) | ||||||||||
Estimated settlement expense 7 | — | (204) | — | (204) | ||||||||||
Acquisition-related costs 8 | — | (45) | — | (45) | ||||||||||
AltEn facility remediation charges 5 | (10) | — | — | (10) | ||||||||||
| Employee Retention Credit | — | 3 | — | 3 | ||||||||||
Seed sale associated with Russia Exit 4,9 | 18 | — | — | 18 | ||||||||||
| Total | $ | (81) | $ | (476) | $ | (22) | $ | (579) | ||||||
1.Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
2.Consists of a charge relating to the resolution of litigation with Bayer. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information.
3.Incremental gains (losses) associated with activities related to the Crop Protection Operations Strategy Restructuring Program. Within gain (loss) on sale of business, assets and equity investments, a $23 million benefit was recorded for the year ended December 31, 2025.
4.Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. Within gain (loss) on sale of business, assets and equity investments, such benefits are $14 million, $7 million and $14 million for the years ended December 31, 2025, 2024 and 2023, respectively.
5.Relates to a charge to increase the remediation accrual at the AltEn facility relating to Corteva's estimated voluntary contribution to the solid waste and wastewater remedial action plans. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information.
6.Includes proceeds received related to prior significant items.
7.Consists of estimated Lorsban® related charges.
8.Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up.
9.Includes a benefit of $18 million for the year ended December 31, 2023, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $71 million of net sales and $53 million of cost of goods sold for the year ended December 31, 2023.
Free Sentinel
Track for freeWant the next EIDP, Inc. segments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment EIDP, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 12, 2026 | Showing above |
| 2024 | Feb 14, 2025 | |
| 2023 | Feb 8, 2024 | |
| 2022 | Feb 9, 2023 | |
| 2021 | Feb 10, 2022 | |
| 2020 | Feb 11, 2021 | |
| 2019 | Feb 14, 2020 | |
| 2016 | Feb 2, 2017 | |
| 2015 | Feb 4, 2016 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.